LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA has added 99,693 shares of $CSL to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 12-31-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $CSL.
CARLISLES Hedge Fund Activity
We have seen 319 institutional investors add shares of CARLISLES stock to their portfolio, and 416 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 717,844 shares (-63.6%) from their portfolio in Q3 2025, for an estimated $236,141,962
- BANK OF NEW YORK MELLON CORP added 558,710 shares (+113.9%) to their portfolio in Q3 2025, for an estimated $183,793,241
- BARCLAYS PLC added 451,662 shares (+947.3%) to their portfolio in Q3 2025, for an estimated $148,578,731
- SANDS CAPITAL MANAGEMENT, LLC added 423,141 shares (+99.2%) to their portfolio in Q3 2025, for an estimated $139,196,463
- JPMORGAN CHASE & CO removed 397,669 shares (-27.7%) from their portfolio in Q3 2025, for an estimated $130,817,194
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 326,108 shares (+79.0%) to their portfolio in Q3 2025, for an estimated $107,276,487
- VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. added 239,560 shares (+inf%) to their portfolio in Q4 2025, for an estimated $76,625,661
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CARLISLES Congressional Stock Trading
Members of Congress have traded $CSL stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CSL stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 08/04.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CARLISLES Analyst Ratings
Wall Street analysts have issued reports on $CSL in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 10/30/2025
- Baird issued a "Outperform" rating on 10/13/2025
To track analyst ratings and price targets for CARLISLES, check out Quiver Quantitative's $CSL forecast page.
CARLISLES Price Targets
Multiple analysts have issued price targets for $CSL recently. We have seen 5 analysts offer price targets for $CSL in the last 6 months, with a median target of $385.0.
Here are some recent targets:
- Tomohiko Sano from JP Morgan set a target price of $400.0 on 10/30/2025
- Keith Hughes from Truist Securities set a target price of $340.0 on 10/30/2025
- Bryan Blair from Oppenheimer set a target price of $415.0 on 10/20/2025
- Susan Maklari from Goldman Sachs set a target price of $385.0 on 10/13/2025
- Timothy Wojs from Baird set a target price of $385.0 on 10/13/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $CSL ticker page for more data.
